Close

Phathom Pharmaceuticals (PHAT) PT Lowered to $58 at BMO Capital, Remains Bullish as Vonoprazan On Track Mar 3, 2022 06:58AM
Phathom Pharmaceuticals Inc. (PHAT) Announces Proposed 5M Share Stock Offering Oct 26, 2021 04:01PM
Phathom Pharmaceuticals Announces Proposed Public Offering of 5,000,000 Shares of Common Stock Oct 26, 2021 04:01PM
Phathom Pharmaceuticals Announces Proposed Public Offering of 5,000,000 Shares of Common Stock Oct 26, 2021 04:01PM
UPDATE: BMO Capital Starts Phathom Pharmaceuticals (PHAT) at Outperform Feb 17, 2021 05:02AM


Dec 17, 2020 06:14AM Phathom Pharmaceuticals Inc. (PHAT) Prices 2.25M Share Common Offering at $42/Sh
Dec 16, 2020 06:43PM Phathom Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Dec 16, 2020 06:43PM Phathom Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Dec 15, 2020 04:02PM Phathom Pharmaceuticals Inc. (PHAT) Announces Proposed 2.5M Common Share Offering
Dec 15, 2020 04:01PM Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock
Dec 15, 2020 04:01PM Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock